Ithaca Is
Mushroom Spirits Distillery LLC — Fayette, NY
New York
About Ithaca Is
Ithaca Is is a vodka brand produced in New York and registered with the Alcohol and Tobacco Tax and Trade Bureau. The spirit is bottled at a proof level between 80 and 89, placing it within the standard range for vodka spirits. According to TTB public records, the brand received its initial label approval in 2020, with a single approved label on file. The brand maintains one distinct product offering currently available through spirits retailers. As a New York-based vodka, Ithaca Is represents the state's continued presence in the spirits market. The brand's single TTB approval indicates a focused product line, with the bottling proof falling within conventional parameters for the vodka category. Information regarding the brand's production methods, specific ingredients, or distribution details beyond its origin state is not available in the public TTB registration records.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
| Ithaca Is VODKA 80-89 PROOF | Vodka 80-89 Proof | Approved | 2020-10-16 | Mushroom Spirits Distillery LLC |
Page 1 of 1
Ithaca Is at a Glance
Ithaca Is has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2020-10-16 and 2020-10-16. Produced in New York.
All information sourced from public TTB records.
Are you the owner or distributor of Ithaca Is?
Claim this brand listing to update information or get featured. Contact [email protected].
Produced At
Mushroom Spirits Distillery LLCRelated Brands
- Svedka also from New York
- Three Olives also from New York
- New Amsterdam also from New York
- Recipe 21 also from New York
- 1911 Established also from New York
- Muscle also makes Vodka 80-89 Proof
- Veil also makes Vodka 80-89 Proof
- Heritage Distilling CO also makes Vodka 80-89 Proof
- Holla also makes Vodka 80-89 Proof
- A.M. Scott Distillery also makes Vodka 80-89 Proof
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.